These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 18360314
1. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Helms DJ, Mosure DJ, Metcalf CA, Douglas JM, Malotte CK, Paul SM, Peterman TA. Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314 [Abstract] [Full Text] [Related]
2. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS. J Infect Dis; 2008 Feb 15; 197(4):548-54. PubMed ID: 18275275 [Abstract] [Full Text] [Related]
3. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS. Clin Infect Dis; 2007 Jan 01; 44(1):13-22. PubMed ID: 17143809 [Abstract] [Full Text] [Related]
4. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. J Infect Dis; 2005 Dec 15; 192(12):2039-44. PubMed ID: 16288365 [Abstract] [Full Text] [Related]
5. Trichomonas vaginalis infection: risk indicators among women attending for routine gynecologic examination. Verteramo R, Calzolari E, Degener AM, Masciangelo R, Patella A. J Obstet Gynaecol Res; 2008 Apr 15; 34(2):233-7. PubMed ID: 18412787 [Abstract] [Full Text] [Related]
6. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Magnus M, Clark R, Myers L, Farley T, Kissinger PJ. Sex Transm Dis; 2003 Nov 15; 30(11):839-43. PubMed ID: 14603092 [Abstract] [Full Text] [Related]
7. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE. Sex Transm Dis; 2010 Jul 15; 37(7):440-4. PubMed ID: 20351623 [Abstract] [Full Text] [Related]
8. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Klinger EV, Kapiga SH, Sam NE, Aboud S, Chen CY, Ballard RC, Larsen U. Sex Transm Dis; 2006 Dec 15; 33(12):712-8. PubMed ID: 16755271 [Abstract] [Full Text] [Related]
9. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations. Roth AM, Williams JA, Ly R, Curd K, Brooks D, Arno J, Van Der Pol B. Sex Transm Dis; 2011 May 15; 38(5):398-400. PubMed ID: 21217417 [Abstract] [Full Text] [Related]
10. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria. Konje JC, Otolorin EO, Ogunniyi JO, Obisesan KA, Ladipo OA. Afr J Med Med Sci; 1991 Mar 15; 20(1):29-34. PubMed ID: 1905467 [Abstract] [Full Text] [Related]
11. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon. Garcia A, Exposto F, Prieto E, Lopes M, Duarte A, Correia da Silva R. Int J STD AIDS; 2004 Sep 15; 15(9):615-8. PubMed ID: 15339370 [Abstract] [Full Text] [Related]
12. Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria. Anorlu RI, Fagbenro Beyioku AF, Fagorala T, Abudu OO, Galadanci HS. Niger Postgrad Med J; 2001 Dec 15; 8(4):183-6. PubMed ID: 11922025 [Abstract] [Full Text] [Related]
13. Sexually transmitted infections among pregnant women attending an antenatal clinic in Fuzhou, China. Chen XS, Yin YP, Chen LP, Thuy NT, Zhang GY, Shi MQ, Hu LH, Yu YH. Sex Transm Dis; 2006 May 15; 33(5):296-301. PubMed ID: 16554698 [Abstract] [Full Text] [Related]
14. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Van der Pol B. Clin Infect Dis; 2007 Jan 01; 44(1):23-5. PubMed ID: 17143810 [No Abstract] [Full Text] [Related]
15. Prevalence and incidence of Trichomonas vaginalis infections in women participating in a clinical trial in Durban, South Africa. Naidoo S, Wand H. Sex Transm Infect; 2013 Sep 01; 89(6):519-22. PubMed ID: 23605853 [Abstract] [Full Text] [Related]
16. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Mavedzenge SN, Pol BV, Cheng H, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, Straten Av. Sex Transm Dis; 2010 Jul 01; 37(7):460-6. PubMed ID: 20562586 [Abstract] [Full Text] [Related]
17. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study. Piperaki ET, Theodora M, Mendris M, Barbitsa L, Pitiriga V, Antsaklis A, Tsakris A. J Clin Pathol; 2010 Mar 01; 63(3):249-53. PubMed ID: 20203225 [Abstract] [Full Text] [Related]
18. Prevalence of sexually transmitted infections among sexually active Jordanian females. Mahafzah AM, Al-Ramahi MQ, Asa'd AM, El-Khateeb MS. Sex Transm Dis; 2008 Jun 01; 35(6):607-10. PubMed ID: 18434942 [Abstract] [Full Text] [Related]
19. Trichomonas vaginalis in Vanuatu. Fotinatos N, Warmington A, Walker T, Pilbeam M. Aust J Rural Health; 2008 Feb 01; 16(1):23-7. PubMed ID: 18186718 [Abstract] [Full Text] [Related]
20. Trichomonas vaginalis infection among women in a low prevalence setting. Uddin RN, Ryder N, McNulty AM, Wray L, Donovan B. Sex Health; 2011 Mar 01; 8(1):65-8. PubMed ID: 21371384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]